Evidence map›Paper›PMID 37895218›Full record

ArticleGenes2023

Occult Macular Dysfunction Syndrome: Identification of Multiple Pathologies in a Clinical Spectrum of Macular Dysfunction with Normal Fundus in East Asian Patients: EAOMD Report No. 5.

Yu Fujinami-Yokokawa, Lizhu Yang, Kwangsic Joo, Kazushige Tsunoda, Xiao Liu, Mineo Kondo, Seong Joon Ahn, Hui Li, Kyu Hyung Park, Hisateru Tachimori and 4 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Phenotypic and Genotypic Characterization of RP1L1-Associated Retinopathy.Investigative ophthalmology & visual science · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 4 countries.

Yu Fujinami-YokokawaDepartment of Health Policy and Management, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0001-7555-5797
Lizhu YangDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China.
Kwangsic JooDepartment of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Republic of Korea.
Kazushige TsunodaDivision of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo 152-8902, Japan.
Xiao LiuLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo 152-8902, Japan.
Mineo KondoDepartment of Ophthalmology, Mie University Graduate School of Medicine, Mie 514-8507, Japan.
Seong Joon AhnDepartment of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.ORCID 0000-0002-4545-8344
Hui LiDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China.
Kyu Hyung ParkDepartment of Ophthalmology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
Hisateru TachimoriEndowed Course for Health System Innovation, Keio University School of Medicine, Tokyo 160-8582, Japan.ORCID 0000-0001-6401-2885
Hiroaki MiyataDepartment of Health Policy and Management, Keio University School of Medicine, Tokyo 160-8582, Japan.
Se Joon WooDepartment of Ophthalmology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Republic of Korea.ORCID 0000-0003-3692-7169
Ruifang SuiDepartment of Ophthalmology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100193, China.
Kaoru FujinamiLaboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, NHO Tokyo Medical Center, Tokyo 152-8902, Japan.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNKeio University · JPSeoul National University Bundang Hospital · KRArmy Medical University · CNHanyang University Seoul Hospital · KRMie University · JPMoorfields Eye Hospital NHS Foundation Trust · GBSeoul National University Hospital · KRTokyo Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Occult macular dystrophy (OMD) is the most prevalent form of macular dystrophy in East Asia. Beyond

Indexed as

Macular DegenerationRetinal DystrophiesCohort StudiesEast Asian PeopleElectroretinographyEye ProteinsHumansRetinaEye ProteinsRP1L1 protein, humanCRXGUCY2Dmiyake diseasenon-RP1L1occult macular dystrophyRP1L1

Identifiers

PMID37895218
PMCPMC10606510
OpenAlexW4387050303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.